vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and LINKBANCORP, Inc. (LNKB). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $46.0M, roughly 1.8× LINKBANCORP, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs 6.4%, a 0.4% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 7.3%). LINKBANCORP, Inc. produced more free cash flow last quarter ($23.8M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
BLLN vs LNKB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $46.0M |
| Net Profit | $5.7M | $2.9M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | 8.5% |
| Net Margin | 6.8% | 6.4% |
| Revenue YoY | 117.4% | 7.3% |
| Net Profit YoY | 138.3% | -61.2% |
| EPS (diluted) | $0.10 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $46.0M | ||
| Q3 25 | $83.5M | $44.8M | ||
| Q2 25 | — | $42.3M | ||
| Q1 25 | — | $53.4M | ||
| Q4 24 | — | $42.9M | ||
| Q3 24 | $38.4M | $42.9M | ||
| Q2 24 | — | $41.3M | ||
| Q1 24 | — | $40.5M |
| Q4 25 | — | $2.9M | ||
| Q3 25 | $5.7M | $7.8M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | — | $15.3M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-14.9M | $7.1M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | — | $5.7M |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 8.5% | ||
| Q3 25 | 11.5% | 22.3% | ||
| Q2 25 | — | 22.4% | ||
| Q1 25 | — | 36.0% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | -32.9% | 21.3% | ||
| Q2 24 | — | 18.0% | ||
| Q1 24 | — | 18.1% |
| Q4 25 | — | 6.4% | ||
| Q3 25 | 6.8% | 17.5% | ||
| Q2 25 | — | 17.5% | ||
| Q1 25 | — | 28.7% | ||
| Q4 24 | — | 17.7% | ||
| Q3 24 | -38.8% | 16.5% | ||
| Q2 24 | — | 14.1% | ||
| Q1 24 | — | 14.1% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | $0.10 | $0.21 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | — | $0.41 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | $-1.47 | $0.19 | ||
| Q2 24 | — | $0.16 | ||
| Q1 24 | — | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $52.3M |
| Total DebtLower is stronger | $55.0M | $177.3M |
| Stockholders' EquityBook value | $-239.5M | $306.4M |
| Total Assets | $327.5M | $3.1B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $52.3M | ||
| Q3 25 | $195.2M | $194.2M | ||
| Q2 25 | — | $155.1M | ||
| Q1 25 | — | $220.2M | ||
| Q4 24 | — | $166.1M | ||
| Q3 24 | — | $191.2M | ||
| Q2 24 | — | $181.7M | ||
| Q1 24 | — | $172.3M |
| Q4 25 | — | $177.3M | ||
| Q3 25 | $55.0M | $102.3M | ||
| Q2 25 | — | $102.3M | ||
| Q1 25 | — | $102.7M | ||
| Q4 24 | — | $112.5M | ||
| Q3 24 | — | $102.4M | ||
| Q2 24 | — | $102.3M | ||
| Q1 24 | — | $102.2M |
| Q4 25 | — | $306.4M | ||
| Q3 25 | $-239.5M | $305.5M | ||
| Q2 25 | — | $298.0M | ||
| Q1 25 | — | $294.1M | ||
| Q4 24 | — | $280.2M | ||
| Q3 24 | $-242.9M | $277.4M | ||
| Q2 24 | — | $271.4M | ||
| Q1 24 | — | $268.2M |
| Q4 25 | — | $3.1B | ||
| Q3 25 | $327.5M | $3.1B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $25.3M |
| Free Cash FlowOCF − Capex | $6.5M | $23.8M |
| FCF MarginFCF / Revenue | 7.7% | 51.7% |
| Capex IntensityCapex / Revenue | 8.8% | 3.2% |
| Cash ConversionOCF / Net Profit | 2.42× | 8.59× |
| TTM Free Cash FlowTrailing 4 quarters | — | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $25.3M | ||
| Q3 25 | $13.8M | $23.6M | ||
| Q2 25 | — | $6.3M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | — | $25.4M | ||
| Q3 24 | — | $14.0M | ||
| Q2 24 | — | $6.4M | ||
| Q1 24 | — | $-771.0K |
| Q4 25 | — | $23.8M | ||
| Q3 25 | $6.5M | $23.2M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | — | $22.6M | ||
| Q3 24 | — | $13.1M | ||
| Q2 24 | — | $6.3M | ||
| Q1 24 | — | $-1.2M |
| Q4 25 | — | 51.7% | ||
| Q3 25 | 7.7% | 51.8% | ||
| Q2 25 | — | 14.5% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 52.6% | ||
| Q3 24 | — | 30.5% | ||
| Q2 24 | — | 15.3% | ||
| Q1 24 | — | -3.0% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 8.8% | 0.8% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | 8.59× | ||
| Q3 25 | 2.42× | 3.01× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 3.35× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
LNKB
Segment breakdown not available.
